Skip to main content
Premium Trial:

Request an Annual Quote

Clarification: Dec 20, 2004


Due to an editing oversight, a quote from Mark Stolorow, executive director of Orchid Cellmark, was truncated in last week’s issue of BioInform. The full quote is as follows: “We have adequate quality assurance controls in place to help us identify and correct any foreseeable quality assurance contingency. If I knew that it weren’t, I would correct it, so we operate under the assumption that we have adequate controls in place, and in the 16 year history of our company here at our Germantown site, that has been the case.”

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.